Perineural Injection Therapy Training for Physicians

Perineural injection therapy (PIT) involves the subcutaneous injection of a low-concentration buffered dextrose solution (typically 5% dextrose) along the course of superficial peripheral nerves that have become chronically irritated and inflamed. The dextrose interacts with TRPV1 receptors on sensory nerve fibers, reducing neurogenic inflammation and restoring normal nerve function. This mechanism addresses the underlying neural dysfunction rather than simply masking pain.

PIT has demonstrated clinical efficacy for chronic neuropathic pain conditions including headaches and migraines, chronic neck and back pain, lateral epicondylitis, Achilles tendinopathy, knee pain, post-surgical pain syndromes, and various other chronic musculoskeletal pain conditions that have a significant neuropathic component. It is particularly valuable for patients who have not responded adequately to conventional pain treatments.

Most patients require a series of four to eight treatment sessions spaced one to two weeks apart, though significant pain reduction is often noticed after the first two to three treatments. Some chronic conditions may require additional maintenance sessions. The course teaches you how to structure multi-session treatment protocols and track clinical outcomes to guide treatment duration.

PIT has an excellent safety profile because the injections are performed subcutaneously (not deep) using a very low-concentration dextrose solution rather than corticosteroids or other medications with systemic side effects. The most common side effect is mild, temporary discomfort at injection sites. The superficial injection depth and benign injectate make PIT one of the safest interventional pain procedures available.

Traditional prolotherapy (regenerative injection therapy) uses higher-concentration dextrose solutions (typically 15-25%) injected into ligament and tendon attachments to stimulate a healing inflammatory response. Perineural injection therapy uses much lower concentrations (5%) injected subcutaneously along superficial nerve pathways to reduce neurogenic inflammation. The targets, mechanisms, and concentrations are distinctly different despite both using dextrose.

Yes, PIT integrates well with other pain management modalities including joint injections, trigger point injections, physical therapy, regenerative medicine treatments, and chiropractic care. Many practitioners use PIT as part of a comprehensive, multi-modal pain management approach that addresses both neuropathic and nociceptive pain components simultaneously.

PIT requires minimal equipment — small gauge needles (typically 27-30 gauge), sterile buffered dextrose solution, syringes, and standard injection supplies. The low equipment cost and absence of expensive imaging or specialized devices make PIT one of the most accessible interventional pain procedures to add to a practice, with virtually no barrier to entry beyond proper training.

Yes, Empire Medical Training's Perineural Injection Therapy Training is fully CME/CE accredited. You receive certification documenting your training in PIT techniques along with earned CME/CE credits applicable to license renewal and professional development requirements for your specific healthcare profession.

Clinical studies and growing research demonstrate PIT efficacy for chronic pain conditions including neuropathic pain, treatment-resistant musculoskeletal pain, and post-surgical pain syndromes. The neurogenic inflammation model and TRPV1 receptor modulation mechanism are well-established in neuroscience. While the evidence base continues to expand, many pain management practitioners report excellent clinical outcomes with PIT, particularly for patients who have failed conventional approaches.

PIT addresses a specific mechanism — neurogenic inflammation — that other pain management techniques do not directly target. It integrates as a complementary modality alongside joint injections, nerve blocks, regenerative medicine, and physical therapy. Many physicians use PIT for patients with significant neuropathic pain components, adding it to multi-modal treatment plans when conventional interventions provide incomplete relief.

Patients generally tolerate PIT very well due to the minimal discomfort of subcutaneous injections and the absence of systemic side effects. The progressive improvement over a series of treatments — often noticeable after two to three sessions — creates strong patient engagement and compliance. Patients who have suffered with refractory chronic pain often become enthusiastic advocates when PIT provides meaningful relief.

While physicians have the legal authority to perform many procedures, hands-on training under expert supervision dramatically accelerates the learning curve, reduces complication risk, and provides the clinical confidence needed to deliver exceptional patient outcomes from day one. Empire's structured curriculum, live patient practice, and CME accreditation also satisfy credentialing and malpractice insurance requirements that self-study alone cannot fulfill.

Adding procedural services creates new revenue streams that can significantly increase your practice income — aesthetic services alone can add $200K-$500K+ in annual revenue. Beyond finances, offering in-demand procedures improves patient retention, attracts new patient demographics, and positions your practice competitively in a market where patients increasingly expect comprehensive service offerings from their healthcare providers.

Yes. All Empire Medical Training courses for physicians are accredited through the Accreditation Council for Continuing Medical Education (ACCME) and provide AMA PRA Category 1 Credit™. These credits satisfy continuing medical education requirements for state license renewal and specialty board Maintenance of Certification (MOC) programs.